Search - tctmd.com

Displaying 101 - 120 of 126

Sort: Relevancy | Date

Presentation THT 2023

When To Transition From Medical to Device-Based Therapy

Presenter: Shelley Hall

March 20, 2023

Presentation THT 2023

SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)

Presenter: Alexandre Mebazaa

March 20, 2023

Presentation THT 2023

SSO2 for AMI Shock: The ISO-Shock Trial (AMI)

Presenter: Babar Basir

March 20, 2023

Presentation THT 2023

Should All ECMO Patients Receive LV Unloading (Include HYPO-ECMO)?

Presenter: Dirk Westermann

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Cardiogenic Shock: Customized Therapeutic Approaches in 2023

Presenter: A. Reshad Garan

March 20, 2023

Presentation THT 2023

Cardiogenic Shock: Patient Phenotyping and Prognostication

Presenter: Manreet Kanwar

March 20, 2023

Presentation THT 2023

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Presenter: Arman Kilic

March 20, 2023

Presentation THT 2023

Outcomes of cardiogenic shock in patients with chronic systolic vs diastolic heart failure: A nationwide analysis

Presenter: Dhairya Nanavaty

March 20, 2023

Presentation THT 2023

The use of Invasive Hemodynamic Monitoring in Patients with Cardiogenic Shock has Increased Over Time: Insights in Trends for Early Mortality, Readmission Rates and Mechanical Circulatory Support Use from the National Readmissions Database

Presenter: Abhinav Aggarwal

March 20, 2023

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Challenges With Cardiogenic Shock Studies in the US

Presenter: Chuck Simonton

February 02, 2022

Presentation THT 2022

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Presenter: Shashank Sinha

February 02, 2022

Presentation THT 2022

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Presenter: Waleed Al-Darzi

February 02, 2022

Presentation THT 2022

Valvular Cardiogenic Shock - Evaluating the Mechanism of Prosthetic Mitral Valve Stenosis

Presenter: Peter Hanna

February 02, 2022

Presentation THT 2022

The Role of ECMO in Management of Cardiogenic Shock

Presenter: Shelley Hall

February 02, 2022

Presentation THT 2022

The Role of IABP in the Management of Cardiogenic Shock

Presenter: Jennifer Cowger

February 02, 2022

Presentation THT 2022

Selective Use of PAC and Impella for Managing Shock is Best For Patients

Presenter: Sunil Rao

February 02, 2022

Presentation THT 2022

Making This Real: Presentation of a Challenging Case

Presenter: Manreet Kanwar

February 02, 2022

Advertisement

When To Transition From Medical to Device-Based Therapy

SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)

SSO2 for AMI Shock: The ISO-Shock Trial (AMI)

Should All ECMO Patients Receive LV Unloading (Include HYPO-ECMO)?

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Cardiogenic Shock: Customized Therapeutic Approaches in 2023

Cardiogenic Shock: Patient Phenotyping and Prognostication

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Outcomes of cardiogenic shock in patients with chronic systolic vs diastolic heart failure: A nationwide analysis

The use of Invasive Hemodynamic Monitoring in Patients with Cardiogenic Shock has Increased Over Time: Insights in Trends for Early Mortality, Readmission Rates and Mechanical Circulatory Support Use from the National Readmissions Database

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Challenges With Cardiogenic Shock Studies in the US

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Valvular Cardiogenic Shock - Evaluating the Mechanism of Prosthetic Mitral Valve Stenosis

The Role of ECMO in Management of Cardiogenic Shock

The Role of IABP in the Management of Cardiogenic Shock

Selective Use of PAC and Impella for Managing Shock is Best For Patients

Making This Real: Presentation of a Challenging Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content